Abstract
Definitive cure of an animal model of a human disease by gene transfer into hematopoietic stem cells has not yet been accomplished in the absence of spontaneous in vivo selection for transduced cells. Erythropoietic protoporphyria is a genetic disease in which ferrochelatase is defective. Protoporphyrin accumulates in erythrocytes, leaks into the plasma and results in severe skin photosensitivity. Using a mouse model of erythropoietic protoporphyria, we demonstrate here that ex vivo preselection of hematopoietic stem cells transduced with a polycistronic retrovirus expressing both human ferrochelatase and green fluorescent protein results in complete and long-term correction of skin photosensitivity in all transplanted mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mardiney, M. III, et al. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 89, 2268–2275 (1997).
Bjorgvinsdottir, H. et al. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatous in murine X-linked chronic granulomatous disease. Blood 89, 41–48 (1997).
Bunting, K., Sangster, M., Ihle J. & Sorrentino, B. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nature Med. 4, 58– 64 (1998).
Desnick, R. in Harrison's Principles of Internal Medicine 13th edn. Vol. 1 (eds. Isselbacher, K.J. et al.) 2073 (McGraw-Hill, New York, 1994).
Mathews-Roth, M., Pathak, M., Fitzpatrick, T., Harber, L. & Kass, E. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases. Arch. Dermatol. 113, 1229–1232 (1977).
Boulechfar, S. et al. Ferrochelatase structural mutant (Fechm1Pas) in the house mouse. Genomics 16, 645– 648 (1993).
Tutois, S. et al. Erythropoietic protoporphyria in the house mouse. A recessive inherited deficiency with anemia, photosensitivity and liver disease. J. Clin. Invest. 88, 1730–1736 (1991).
Zimmermann, A. Consequences of cholestasis from the pathologist's viewpoint. Schweiz. Med. Wochenschr. 127, 812– 820 (1997).
Perez-Tamayo, R. Cirrhosis of the liver: a reversible disease? Pathol. Annu. 14 183–213 (1979).
Markowitz, D., Goff, S. & Bank, A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62, 1120 (1988).
Anderson, W. Human gene therapy. Nature 392, 25– 30 (1998).
Verma, I. & Somia, N. Gene therapy-promises, problems and prospects. Nature 389, 239– 242 (1997).
Pawliuk, R., Eaves, C. & Humphries, R. Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen. Hum. Gene Ther. 8, 1595– 1604 (1997).
Youssoufian, H. Natural gene therapy and the Darwinian legacy. Nature Genet. 13, 255–256 (1996).
Cheng, L. et al. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood 92, 83–92 (1998).
Conneally, E., Eaves, C. & Humphries, R. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 91, 3487–3493 (1998).
Huang, Z. & Yen, T. Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol. Cell. Biol. 15, 3864–3869 (1995).
Persons, D. et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90, 1777– 1786 (1997).
Leboulch, P. et al. Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure. EMBO J. 13, 3065–3076 (1994).
Raftopoulos, H., Ward, M. & Bank, A. Long-term transfer and expression of the human beta-globin gene in a mouse transplant model. Blood 90, 3414– 3422 (1997).
Torres de, I., Demetris, A. & Randhawa, P. Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation 61, 1412–1413 (1996).
Hawley, R., Lieu, F., Fong, A. & Hawley, T. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1, 136–138 (1994).
Nakahashi, Y., Taketani, S., Okuda, M., Inoue, K. & Tokunaga, R. Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase. Biochem. Biophys. Res. Commun. 173, 748–755 (1990).
Pear, W., Nolan, G., Scott, M. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392– 8396 (1993).
Markowitz, D., Goff, S. & Bank, A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400–406 (1988).
Pawliuk, R., Kay, R., Lansdorp, P. & Humphries, R. K. Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer. Blood 84, 2868– 2877 (1994).
Sorrentino, B. et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99–103 (1992).
Piomelli, S. Free erythrocyte protoporphyrins in the detection of undue absorption of Pb and of Fe deficiency. Clin. Chem. 23, 264–269 (1977).
Acknowledgements
We thank J. Sanchez-Salazar, O. Zurkyia and G. Paradis for their technical assistance. We are grateful to J. Fox for liver function analyses and pathology from the MIT Division of Comparative Medicine. This work was supported by NIH grant HL55435 to P.L. and by the Erythropoietic Protoporphyria Research & Education Fund to M. M.-R.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pawliuk, R., Bachelot, T., Wise, R. et al. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy. Nat Med 5, 768–773 (1999). https://doi.org/10.1038/10488
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/10488
This article is cited by
-
Skin Ferrochelatase and Photosensitivity in Mice and Man
Journal of Investigative Dermatology (2010)
-
Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection
Gene Therapy (2004)
-
Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells
Journal of Molecular Medicine (2003)
-
Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell
Leukemia (2002)
-
Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells
Gene Therapy (2001)